Program News
News and stories about members of the UNC Lineberger Breast Cancer Research Program
-
UNC School of Medicine oncologist named recipient of Winn Clinical Investigator Leadership Award
Yara Abdou, MD, is among the third cohort of physician researchers to receive the Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award.
-
UNC Lineberger researchers among world’s most influential in Clarivate 2025 Highly Cited Researchers list
Eleven UNC Lineberger Comprehensive Cancer Center members were named as 2025 Highly Cited Researchers by Clarivate for publishing some of the most influential scientific papers during the past decade.
-
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.
-
Carey named a ‘Giant’ of breast cancer care
Lisa Carey, MD, ScM, FASCO, was honored by OncLive as one of its 2025 Giants of Cancer Care for her significant contributions advancing the treatment and study of breast cancer.
-
UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.
-
UNC Lineberger faculty and trainees present research, receive honors at cancer research meeting
UNC Lineberger faculty and trainees presented research findings and participated in panel discussions at the American Society of Clinical Oncology’s annual meeting in Chicago.
-
‘Breast cancer is a team sport’
Lisa Carey, MD, ScM, FASCO, talks about the importance of research, coordinated care and helping patients make informed choices.
-
UNC faculty and trainees to present at the world’s largest clinical cancer research meeting
UNC faculty and trainees will share their latest research findings and clinical insights during talks, poster presentations and panel discussions during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.
-
Trial and discovery
Carolina researchers are pushing the boundaries of medicine through clinical trials — driving innovation, uncovering new therapies, and shaping a future where science transforms lives.
-
Five UNC Lineberger members named distinguished professors
Five cancer center members were named distinguished professors, an honor recognizing those who exemplify the highest standards of UNC through their scholarly achievement, teaching excellence and service.
-
UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting
Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.
-
Experimental CAR-M immunotherapy shows promise in solid tumors
UNC Lineberger researchers report their findings that an experimental immunotherapy using chimeric antigen receptor macrophages (CAR-M) is safe and helps activate the body’s immune system against certain solid cancers.
-
Troester elected chair of the AACR Populations Sciences Working Group
Melissa Troester, PhD, MPH, will serve as chair-elect and will assume the role of chair for the 2026-2028 term at the 2026 AACR Annual Meeting.
-
International breast cancer meeting features UNC Lineberger research
More than 10,000 cancer researchers, clinicians and patient advocates from across the globe are expected to attend this year’s San Antonio Breast Cancer Symposium. The meeting will feature presentations by several UNC faculty members and trainees.
-
UNC researchers awarded up to $10M to leverage data science to accelerate cancer diagnosis and optimize delivery of precision oncology
A team of UNC-Chapel Hill researchers has received nearly $10 million in funding to develop the Cancer Identification and Precision Oncology Center.